LAP2 Is Widely Overexpressed in Diverse Digestive Tract Cancers and Regulates Motility of Cancer Cells

Background Lamina-associated polypeptides 2 (LAP2) is a nuclear protein that connects the nuclear lamina with chromatin. Although its critical roles in genetic disorders and hematopoietic malignancies have been described, its expression and roles in digestive tract cancers have been poorly characterized. Methods To examine the expression of LAP2 in patient tissues, we performed immunohistochemistry and real-time PCR. To examine motility of cancer cells, we employed Boyden chamber, wound healing and Matrigel invasion assays. To reveal its roles in metastasis in vivo, we used a liver metastasis xenograft model. To investigate the underlying mechanism, a cDNA microarray was conducted. Results Immunohistochemistry in patient tissues showed widespread expression of LAP2 in diverse digestive tract cancers including stomach, pancreas, liver, and bile duct cancers. Real-time PCR confirmed that LAP2β is over-expressed in gastric cancer tissues. Knockdown of LAP2β did not affect proliferation of most digestive tract cancer cells except pancreatic cancer cells. However, knockdown of LAP2β decreased motility of all tested cancer cells. Moreover, overexpression of LAP2β increased motility of gastric and pancreatic cancer cells. In the liver metastasis xenograft model, LAP2β increased metastatic efficacy of gastric cancer cells and mortality in tested mice. cDNA microarrays showed the possibility that myristoylated alanine-rich C kinase substrate (MARCKS) and interleukin6 (IL6) may mediate LAP2β-regulated motility of cancer cells. Conclusions From the above results, we conclude that LAP2 is widely overexpressed in diverse digestive tract cancers and LAP2β regulates motility of cancer cells and suggest that LAP2β may have utility for diagnostics and therapeutics in digestive tract cancers.

[1]  D. Fuchs,et al.  The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1 , 2007, Oncogene.

[2]  N. Copeland,et al.  Nuclear membrane protein LAP2beta mediates transcriptional repression alone and together with its binding partner GCL (germ-cell-less). , 2001, Journal of cell science.

[3]  P. Janmey,et al.  MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium–calmodulin , 1992, Nature.

[4]  H. Saya,et al.  Myristoylated alanine‐rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C‐dependent pathway , 2010, Cancer science.

[5]  Giacomo Finocchiaro,et al.  Lap2alpha expression is controlled by E2F and deregulated in various human tumors. , 2006, Cell cycle.

[6]  S. Ashley,et al.  Differential display of expressed genes in pancreatic cancer cells. , 2002, Biochemical and biophysical research communications.

[7]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[8]  R. Foisner,et al.  Lamins and lamin-associated proteins in aging and disease. , 2007, Current opinion in cell biology.

[9]  T. Toda,et al.  Expression of thymopoietin beta/lamina-associated polypeptide 2 (TP beta/LAP2) and its family proteins as revealed by specific antibody induced against recombinant human thymopoietin. , 1996, Biochemical and biophysical research communications.

[10]  W. Cavenee,et al.  A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  N. Amariglio,et al.  Enhanced expression of the nuclear envelope LAP2 transcriptional repressors in normal and malignant activated lymphocytes , 2007, Annals of Hematology.

[12]  S. Manilal,et al.  The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. , 1996, Human molecular genetics.

[13]  Crafford A. Harris,et al.  Roles of LAP2 Proteins in Nuclear Assembly and DNA Replication: Truncated LAP2β Proteins Alter Lamina Assembly, Envelope Formation, Nuclear Size, and DNA Replication Efficiency in Xenopus laevis Extracts , 1999, The Journal of cell biology.

[14]  R. Foisner,et al.  Review: lamina-associated polypeptide 2 isoforms and related proteins in cell cycle-dependent nuclear structure dynamics. , 2000, Journal of structural biology.

[15]  H. Yoshiji,et al.  Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver. , 2005, International journal of oncology.

[16]  M. Paulin-Levasseur,et al.  MAN1, an Inner Nuclear Membrane Protein That Shares the LEM Domain with Lamina-associated Polypeptide 2 and Emerin* , 2000, The Journal of Biological Chemistry.

[17]  J. Siekierka,et al.  Three distinct human thymopoietins are derived from alternatively spliced mRNAs. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Moran,et al.  Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression. , 2009, Cancer research.

[19]  Chi-Ying F. Huang,et al.  IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[20]  R. Foisner,et al.  Integral membrane proteins of the nuclear envelope interact with lamins and chromosomes, and binding is modulated by mitotic phosphorylation , 1993, Cell.

[21]  Gang Li,et al.  IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines , 2010, Journal of Neuro-Oncology.

[22]  Philippe Debeer,et al.  Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis , 2004, Nature Genetics.

[23]  Cross-talk unfolded: MARCKS proteins. , 2002, The Biochemical journal.

[24]  H. Worman.  Inner nuclear membrane and regulation of Smad-mediated signaling. , 2006, Biochimica et biophysica acta.

[25]  K. Wilson,et al.  C. elegans nuclear envelope proteins emerin, MAN1, lamin, and nucleoporins reveal unique timing of nuclear envelope breakdown during mitosis. , 2000, Molecular biology of the cell.

[26]  L. Mestroni,et al.  Thymopoietin (lamina‐associated polypeptide 2) gene mutation associated with dilated cardiomyopathy , 2005, Human mutation.

[27]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[28]  Helen H. W. Chen,et al.  Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion , 2006, Oncogene.

[29]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[30]  N. Amariglio,et al.  The nuclear-envelope protein and transcriptional repressor LAP2β interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation , 2005, Journal of Cell Science.

[31]  F. Opdam,et al.  Jak kinase activity is required for lymphoma invasion and metastasis , 2004, Oncogene.

[32]  永野 敦.  Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy , 1996 .

[33]  S. Young,et al.  Man1, an inner nuclear membrane protein, regulates vascular remodeling by modulating transforming growth factor β signaling , 2006 .

[34]  G. Folkers,et al.  On the Role of Thymopoietins in Cell Proliferation. Immunochemical Evidence for New Members of the Human Thymopoietin Family , 1999, Biological chemistry.

[35]  N. Copeland,et al.  The characterization and localization of the mouse thymopoietin/lamina-associated polypeptide 2 gene and its alternatively spliced products. , 1996, Genome research.

[36]  D. Santini,et al.  IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. , 2007, The Journal of clinical investigation.

[37]  E. Maestrini,et al.  Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy , 1994, Nature Genetics.

[38]  Erwin G. Van Meir,et al.  Human glioblastoma cells release interleukin 6 in vivo and in vitro. , 1990, Cancer research.

[39]  P. Collas,et al.  HA95 and LAP2β mediate a novel chromatin–nuclear envelope interaction implicated in initiation of DNA replication , 2003, The Journal of cell biology.

[40]  F. Ali-Osman,et al.  Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis , 2004, Oncogene.

[41]  Giacomo Finocchiaro,et al.  Lap2α Expression is Controlled by E2F and Deregulated in Various Human Tumors , 2006 .

[42]  N. Hynes,et al.  Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. , 2001, Cancer research.

[43]  P. Heinrich,et al.  Inhibition of gp130 Signaling in Breast Cancer Blocks Constitutive Activation of Stat3 and Inhibits in Vivo Malignancy , 2004, Cancer Research.

[44]  Juliet A. Ellis,et al.  The inner nuclear membrane protein Emerin regulates β‐catenin activity by restricting its accumulation in the nucleus , 2006, The EMBO journal.

[45]  U. Aebi,et al.  Cloning of a cDNA for lamina‐associated polypeptide 2 (LAP2) and identification of regions that specify targeting to the nuclear envelope. , 1995, The EMBO journal.

[46]  Didier Merlin,et al.  Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. , 2007, Cancer research.

[47]  R. Foisner,et al.  LEM2 is a novel MAN1-related inner nuclear membrane protein associated with A-type lamins , 2005, Journal of Cell Science.

[48]  G. Krohne,et al.  LEM-Domain proteins: new insights into lamin-interacting proteins. , 2007, International review of cytology.

[49]  M. Paulin-Levasseur,et al.  The lamina-associated polypeptide 2 (LAP2) isoforms β, γ andω of zebrafish: developmental expression and behavior during the cell cycle , 2003, Journal of Cell Science.

[50]  J. Lewis,et al.  Targeting tumor cell motility to prevent metastasis. , 2011, Advanced drug delivery reviews.